Table 5.

Characterization according to biological age of the different erythrocyte density fractions obtained from controls and diabetic patients

ParameterFractionControlsDiabetic patients
Creatine, mg/100 cells 4.31 ± 0.86 4.84 ± 0.91 
 3.93 ± 0.74 4.20 ± 0.78 
 1.62 ± 0.345-151 1.73 ± 0.325-151 
 1.55 ± 0.295-151 1.61 ± 0.345-151 
 0.54 ± 0.115-151 0.63 ± 0.095-151 
HbA1c, % 3.51 ± 0.39 3.84 ± 0.45 
 3.93 ± 0.425-150 4.96 ± 0.385-151,5-152 
 4.25 ± 0.515-151 6.23 ± 0.535-151,5-152 
 4.56 ± 0.585-151 7.11 ± 0.685-151,5-152 
 5.12 ± 0.495-151 8.23 ± 0.775-151,5-152 
MCH, pg 28.2 ± 2.0 27.5 ± 1.7 
 28.4 ± 1.7 28.8 ± 1.9 
 28.6 ± 1.9 28.8 ± 2.1 
 29.1 ± 2.1 29.0 ± 2.1 
 29.5 ± 1.8 28.9 ± 2.0  
MCHC, g/L 289 ± 24 275 ± 28 
 301 ± 19 299 ± 23 
 316 ± 235-150 310 ± 295-150 
 329 ± 205-151 323 ± 285-151 
 338 ± 215-151 333 ± 315-151 
MCV, fL 97.4 ± 11.9 98.6 ± 11.3 
 94.2 ± 10.9 96.1 ± 10.8 
 90.8 ± 9.4 92.9 ± 9.7 
 88.6 ± 8.8 90.7 ± 8.1 
 84.6 ± 9.55-150 86.7 ± 7.95-150 
ParameterFractionControlsDiabetic patients
Creatine, mg/100 cells 4.31 ± 0.86 4.84 ± 0.91 
 3.93 ± 0.74 4.20 ± 0.78 
 1.62 ± 0.345-151 1.73 ± 0.325-151 
 1.55 ± 0.295-151 1.61 ± 0.345-151 
 0.54 ± 0.115-151 0.63 ± 0.095-151 
HbA1c, % 3.51 ± 0.39 3.84 ± 0.45 
 3.93 ± 0.425-150 4.96 ± 0.385-151,5-152 
 4.25 ± 0.515-151 6.23 ± 0.535-151,5-152 
 4.56 ± 0.585-151 7.11 ± 0.685-151,5-152 
 5.12 ± 0.495-151 8.23 ± 0.775-151,5-152 
MCH, pg 28.2 ± 2.0 27.5 ± 1.7 
 28.4 ± 1.7 28.8 ± 1.9 
 28.6 ± 1.9 28.8 ± 2.1 
 29.1 ± 2.1 29.0 ± 2.1 
 29.5 ± 1.8 28.9 ± 2.0  
MCHC, g/L 289 ± 24 275 ± 28 
 301 ± 19 299 ± 23 
 316 ± 235-150 310 ± 295-150 
 329 ± 205-151 323 ± 285-151 
 338 ± 215-151 333 ± 315-151 
MCV, fL 97.4 ± 11.9 98.6 ± 11.3 
 94.2 ± 10.9 96.1 ± 10.8 
 90.8 ± 9.4 92.9 ± 9.7 
 88.6 ± 8.8 90.7 ± 8.1 
 84.6 ± 9.55-150 86.7 ± 7.95-150 

All data are mean ± SD of 10 different experiments.

F5-150

P < .05.

F5-151

P < .01, “R” versus fractions.

F5-152

P < .01, diabetic patients versus controls.

or Create an Account

Close Modal
Close Modal